STENTYS May Solve One of The Biggest Problems In Acute Coronary Syndrome
Gonzague Issenmann, CEO and co-founder of STENTYS, spoke with OneMedRadio and shared his insights on the industry and how the company has become a success.
OneMedRadio
The Wallace H. Coulter Foundation Optimizes Academia Process
“We have very clear timelines, milestones, and we define the critical experiment that, if it’s successful will bring value to the technology and make it ready for follow-up funding.”
ImmunoGenetix Discovers a Safer Approach To HIV Treatment
James Laufenberg, CEO of ImmunoGenetix was interviewed by OneMedRadio where he discussed a therapeutic DNA based composition to treat HIV, GenePro.
Advaxis CEO Tom Moore Discovers A New Way To Fight Cancer
OneMedRadio interviewed Tom Moore, CEO and Chairman of the Board of Directors of Advaxis [OTC:ADXS]. He discusses the company’s novel immunotherapy technology.
David Strupp Discusses Rodman and Renshaw One Of The Largest Investment Conferences Worldwide
Considered to be bankers for the growth industry, Rodman and Renshaw goes beyond the life science industries.
Wound Management Proves Strong Potential With Distribution Agreements In Place
OneMedRadio interviewed President and Director Deborah Jenkins Hutchinson and got a glimpse into this emerging growth company.
Verisante Technologies Detects Skin Cancer in Less Than A Second
OneMedRadio interviewed Thomas Braun, CEO of Verisante Technologies [CVE:VRS], a medical device company committed to commercializing innovative systems for the early detection of cancer.
ThermoGenesis Sees Explosive Growth Opportunities in Stem Cells
Mel Engle, CEO of ThermoGenesis [NASDAQ: KOOL] recently discussed with OneMedRadio, the company’s stem cell products and FDA approval that may have groundbreaking implications for the stem cell market.
September 26-28 AdvaMed 2011
Kenneth Mendez discusses this year’s MedTech Conference for CEOs, business executives, policy makers, financiers, media, and industry stakeholders from around the world.
International Stem Cell Corp Develops Similar Embryonic Stem Cells Without Fertilized Embryos
Ken Aldrich, Executive Chairman of International Stem Cell [OTC:ISCO] was interviewed by OneMedRadio where he discussed the company’s regenerative medicine therapies.